3 New COVID-19 Treatments Now Available to MS Patients in UK

3 New COVID-19 Treatments Now Available to MS Patients in UK

314785

3 New COVID-19 Treatments Now Available to MS Patients in UK

People with multiple sclerosis (MS) living in the U.K. are now eligible to receive one of three new treatments for COVID-19 that are meant to prevent serious disease in at-risk populations who tested positive for the virus. First available under this plan were Regeneron and Roche’s antibody-based therapy Ronapreve (casirivimab/imdevimab), and the antiviral pill Lagevrio (molnupiravir), developed by Ridgeback Biotherapeutics and Merck Sharp and Dohme (MSD; known as Merck in North America). Xevudy (sotrovimab), an…

You must be logged in to read/download the full post.